0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lupus Nephritis - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-242
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Lupus Nephritis Epidemiology Forecast to 2028

Lupus Nephritis - Epidemiology Forecast to 2028

Code: DELV-Epid-242
Report
April 2019
Pages:50
Delveinsight
Description
Table of Content
Tables & Figures

DelveInsight's "Lupus Nephritis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Lupus Nephritis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Lupus Nephritis Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Lupus Nephritis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Lupus Nephritis outlook. It also includes the explanation of changing trends of epidemiology outlining the Lupus Nephritis scenario.

Lupus Nephritis Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Lupus Nephritis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Lupus Nephritis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Lupus Nephritis Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Lupus Nephritis

Key assessments
• Patient Segmentation in Lupus Nephritis
• Lupus Nephritis Risk & Burden
• Factors driving growth in a specific Lupus Nephritis patient population

1. Report Introduction
2. Lupus Nephritis Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Lupus Nephritis in 2016
2.2. Patient Share Distribution of Lupus Nephritis in 2028
3. Disease Background and Overview: Lupus Nephritis
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Lupus Nephritis in 7MM
4.3. Total Prevalent/ Incident Patient Population of Lupus Nephritis in 7MM – By Countries
5. Epidemiology of Lupus Nephritis by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Lupus Nephritis
5.1.3. Sub-Type Specific cases of the Lupus Nephritis *
5.1.4. Sex- Specific Cases of the Lupus Nephritis *
5.1.5. Diagnosed Cases of the Lupus Nephritis
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Lupus Nephritis
5.4.3. Sub-Type Specific cases of the Lupus Nephritis *
5.4.4. Sex- Specific Cases of the Lupus Nephritis *
5.4.5. Diagnosed Cases of the Lupus Nephritis
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Lupus Nephritis
5.5.3. Sub-Type Specific cases of the Lupus Nephritis *
5.5.4. Sex- Specific Cases of the Lupus Nephritis *
5.5.5. Diagnosed Cases of the Lupus Nephritis
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Lupus Nephritis
5.6.3. Sub-Type Specific cases of the Lupus Nephritis *
5.6.4. Sex- Specific Cases of the Lupus Nephritis *
5.6.5. Diagnosed Cases of the Lupus Nephritis
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Lupus Nephritis
5.7.3. Sub-Type Specific cases of the Lupus Nephritis *
5.7.4. Sex- Specific Cases of the Lupus Nephritis *
5.7.5. Diagnosed Cases of the Lupus Nephritis
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Lupus Nephritis
5.8.3. Sub-Type Specific cases of the Lupus Nephritis *
5.8.4. Sex- Specific Cases of the Lupus Nephritis *
5.8.5. Diagnosed Cases of the Lupus Nephritis
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Lupus Nephritis
5.9.3. Sub-Type Specific cases of the Lupus Nephritis *
5.9.4. Sex- Specific Cases of the Lupus Nephritis *
5.9.5. Diagnosed Cases of the Lupus Nephritis
6. Unmet Needs of the Lupus Nephritis
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Lupus Nephritis in 7MM
Table 2: Total Prevalent/Incident Cases of the Lupus Nephritis in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Lupus Nephritis in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Lupus Nephritis in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Lupus Nephritis in United States (2016-2028)*
Table 6: Diagnosed Cases of the Lupus Nephritis in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Lupus Nephritis in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Lupus Nephritis in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Lupus Nephritis in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Lupus Nephritis in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Lupus Nephritis in France (2016-2028)
Table 12: Sub-Type Specific cases of the Lupus Nephritis in France (2016-2028) *
Table 13: Sex- Specific Cases of the Lupus Nephritis in France (2016-2028) *
Table 14: Diagnosed Cases of the Lupus Nephritis in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Lupus Nephritis in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Lupus Nephritis in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Lupus Nephritis in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Lupus Nephritis in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Lupus Nephritis in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Lupus Nephritis in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Lupus Nephritis in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Lupus Nephritis in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Lupus Nephritis in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Lupus Nephritis in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Lupus Nephritis in UK (2016-2028) *
Table 26: Diagnosed Cases of the Lupus Nephritis in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Lupus Nephritis in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Lupus Nephritis in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Lupus Nephritis in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Lupus Nephritis in Japan (2016-2028)

Listof figures :

Figure 1: Total Prevalent/Incident Cases of the Lupus Nephritis in 7MM
Figure 2: Total Prevalent/Incident Cases of the Lupus Nephritis in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Lupus Nephritis in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Lupus Nephritis in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Lupus Nephritis in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Lupus Nephritis in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Lupus Nephritis in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Lupus Nephritis in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Lupus Nephritis in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Lupus Nephritis in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Lupus Nephritis in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Lupus Nephritis in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Lupus Nephritis in France (2016-2028) *
Figure 14: Diagnosed Cases of the Lupus Nephritis in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Lupus Nephritis in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Lupus Nephritis in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Lupus Nephritis in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Lupus Nephritis in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Lupus Nephritis in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Lupus Nephritis in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Lupus Nephritis in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Lupus Nephritis in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Lupus Nephritis in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Lupus Nephritis in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Lupus Nephritis in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Lupus Nephritis in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Lupus Nephritis in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Lupus Nephritis in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Lupus Nephritis in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Lupus Nephritis in Japan (2016-2028)

SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3250

This license allows only one user to access the PDF.
Electronic (PDF)

$6500

This license allows all the users of an enterprise residing in one location to access the PDF
Electronic (PDF)

$9750

This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Human DNA Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-7S2745
Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Measles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34D11827
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Vaccine Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Z7701
Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Vaccine Freezers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34W13373
Tue Oct 08 00:00:00 UTC 2024

Add to Cart